Exenatide Reduces Urinary Transforming Growth Factor-β1 and Type IV Collagen Excretion in Patients with Type 2 Diabetes and Microalbuminuria
Year: 2012
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Kidney & Blood Pressure Research
DOI: 10.1159/000337929
Institution: Nanjing Medical University
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2013886254
